We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia, cardiocirculatory dysfunction, portal hypertension, and systemic inflammation in patients with decompensated cirrhosis with and without bacterial infections
Cirrhosis is characterized by a prolonged asymptomatic period in which the inflammation persists, in...
Introduction: Circulating prostaglandin E2 levels are elevated in acutely decompensated cirrhosi...
Background Evidence is scarce on the efficacy of long-term human albumin (HA) administration in pati...
Background & Aims: We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia...
BACKGROUND & AIMS: We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia...
We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia, cardiocirculatory...
Purpose of Review: Albumin administration is recommended to prevent or treat specific complications ...
Infection and increased systemic inflammation cause organ dysfunction and death in patients with dec...
The pathophysiological Background: of decompensated cirrhosis is characterised by a systemic proinfl...
SummaryHuman serum albumin (HSA) is one of the most frequent treatments in patients with decompensat...
The use of albumin in patients with cirrhosis has been extensively discussed over recent years. Curr...
Background Evidence is scarce on the efficacy of long-term human albumin (HA) administration in pati...
Liver disease is the only major cause of mortality currently increasing in the UK and is the fifth m...
Cirrhosis is characterized by a prolonged asymptomatic period in which the inflammation persists, in...
Introduction: Circulating prostaglandin E2 levels are elevated in acutely decompensated cirrhosi...
Background Evidence is scarce on the efficacy of long-term human albumin (HA) administration in pati...
Background & Aims: We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia...
BACKGROUND & AIMS: We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia...
We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia, cardiocirculatory...
Purpose of Review: Albumin administration is recommended to prevent or treat specific complications ...
Infection and increased systemic inflammation cause organ dysfunction and death in patients with dec...
The pathophysiological Background: of decompensated cirrhosis is characterised by a systemic proinfl...
SummaryHuman serum albumin (HSA) is one of the most frequent treatments in patients with decompensat...
The use of albumin in patients with cirrhosis has been extensively discussed over recent years. Curr...
Background Evidence is scarce on the efficacy of long-term human albumin (HA) administration in pati...
Liver disease is the only major cause of mortality currently increasing in the UK and is the fifth m...
Cirrhosis is characterized by a prolonged asymptomatic period in which the inflammation persists, in...
Introduction: Circulating prostaglandin E2 levels are elevated in acutely decompensated cirrhosi...
Background Evidence is scarce on the efficacy of long-term human albumin (HA) administration in pati...